Valued Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.03K Buy
14
+1
+8% +$480 ﹤0.01% 375
2026
Q1
$6.4K Buy
13
+12
+1,200% +$6.51K ﹤0.01% 352
2025
Q4
$582 Buy
+1
New +$566 ﹤0.01% 524
2025
Q3
Sell
-3
Closed -$1.4K 626
2025
Q2
$1.22K Sell
3
-9
-75% -$3.76K ﹤0.01% 425
2025
Q1
$5.98K Hold
12
﹤0.01% 285
2024
Q4
$6.25K Sell
12
-2
-14% -$1.1K ﹤0.01% 277
2024
Q3
$8.66K Buy
14
+7
+100% +$4.14K 0.01% 232
2024
Q2
$3.87K Buy
7
+2
+40% +$1.15K ﹤0.01% 297
2024
Q1
$2.91K Sell
5
-9
-64% -$5.05K ﹤0.01% 311
2023
Q4
$7.09K Buy
+14
New +$6.78K 0.01% 157

Other funds holding TMO

Valued Wealth Advisors's TMO Position: Q2 2026 in Review

Valued Wealth Advisors increased its Thermo Fisher Scientific (TMO) stake by 7.7% in Q2 2026, buying an estimated $480 and bringing the position to 14 shares worth $7.03K. The position accounts for ﹤0.01% of the portfolio, ranked #375.

Valued Wealth Advisors first reported a position in TMO in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.66K in Q3 2024. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Valued Wealth Advisors held 14 shares of Thermo Fisher Scientific worth $7.03K as of Q2 2026.
  • Valued Wealth Advisors bought 1 Thermo Fisher Scientific share in Q2 2026, an estimated $480.
  • Thermo Fisher Scientific made up ﹤0.01% of Valued Wealth Advisors's portfolio in Q2 2026, its #375 holding.
  • Valued Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 10 quarters since.
  • Valued Wealth Advisors's Thermo Fisher Scientific position peaked at $8.66K in Q3 2024.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.